RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$3.30
-0.91%
-0.03
Notify me if price changes either direction
Buy RXRX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.7B
Enterprise value
1.1B
Trailing PE
-2.2812500596046
Forward PE
-3.854425
PEG Ratio
0.037783204112202
Enterprise to EBITDA
-1.989
Enterprise to revenue
15.031
Price to book MRQ
1.5319943
Price to sales TTM
23.198719
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
74.7M
EBITDA
-564430976
Diluted EPS TTM
-1.44
Total Cash (MRQ)
743.3M
Current ratio (MRQ)
5.503
Operating Cash Flow (TTM)
-371808000
RXRX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
April 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
